Persistent Systems acquires Herald Health for $5.2mn
The deal for the US tech startup has bee...
The Pune-based technology services system, Persistent Systems, has announced its acquisition of Herald Health.
The deal for the US tech startup has been valued at US$5.2mn – with $2.3mn paid upfront and the remaining $2.9mn to be offered as a deferred payment for management employees over a period of three years, dependant on performance.
Herald Health has focused on the implementation of platforms and IT services within healthcare, contributing to Persistent System’s portfolio.
“This acquisition further strengthens our IP portfolio in healthcare that includes our co-innovation work with leading university health systems and research organizations, as well as solutions that we’ve built jointly with our partner ecosystem,” stated Rahul Patel, General Manager of Healthcare Solutions at Persistent Systems.
“This kind of innovation by Herald Health is driving change in healthcare. It’s not enough just to collect data, you have to give providers user-friendly tools and actionable insights in real time.”
“Herald Health has proven that when you do this in even one hospital, hundreds of doctors and thousands of patients can benefit.”
“When I began my clinical training, I was both impressed at how much data modern medicine can generate on patients and shocked at how few tools physicians were given to effectively process all of that data,” remarked Brad Diephuis, Managing Director and Co-founder of Herald Health.
“At Herald, we’re continually discovering how pervasive this problem is – not just for doctors, but for care coordinators, operations personnel, and hospital leadership – and building innovative solutions to make use of data in real time on the frontlines.”
“With Persistent’s resources and technical expertise, we’re looking forward to scaling these solutions to more hospitals and patients.”
Skin Analytics wins NHSX award for AI skin cancer tool
An artificial intelligence-driven tool that identifies skin cancers has received an award from NHSX, the NHS England and Department of Health and Social Care's initiative to bring technology into the UK's national health system.
NHSX has granted the Artificial Intelligence in Health and Care Award to DERM, an AI solution that can identify 11 types of skin lesion.
Developed by Skin Analytics, DERM analyses images of skin lesions using algorithms. Within primary care, Skin Analytics will be used as an additional tool to help doctors with their decision making.
In secondary care, it enables AI telehealth hubs to support dermatologists with triage, directing patients to the right next step. This will help speed up diagnosis, and patients with benign skin lesions can be identified earlier, redirecting them away from dermatology departments that are at full capacity due to the COVID-19 backlog.
Cancer Research has called the impact of the pandemic on cancer services "devastating", with a 42% drop in the number of people starting cancer treatment after screening.
DERM is already in use at University Hospitals Birmingham and Mid and South Essex Health & Care Partnership, where it has led to a significant reduction in unnecessary referrals to hospital.
Now NHSX have granted it the Phase 4 AI in Health and Care Award, making DERM available to clinicians across the country. Overall this award makes £140 million available over four years to accelerate the use of artificial intelligence technologies which meet the aims of the NHS Long Term Plan.
Dr Lucy Thomas, Consultant Dermatologist at Chelsea & Westminster Hospital, said: “Skin Analytics’ receipt of this award is great news for the NHS and dermatology departments. It will allow us to gather real-world data to demonstrate the benefits of AI on patient pathways and workforce challenges.
"Like many services, dermatology has severe backlogs due to the COVID-19 pandemic. This award couldn't have come at a better time to aid recovery and give us more time with the patients most in need of our help.”